NaviCam - Model Xpress - Stomach System
Introducing the NaviCam® Xpress™ Stomach System, an advanced technology that combines magnetic control with innovative software to give physicians a 360° view of the stomach. The system incorporates three-dimension translational and two dimension rotational control to guide precise movement of the capsule inside the stomach. The NaviCam® Xpress ™ System can be used in clinics and hospitals, including the ER setting and is intended for adults (>/= 22 years old) with a BMI less than 38.
NAVICAM® STOMACH CAPSULE
The ingestible NaviCam® capsule is a pill-sized video camera that the patient swallows with water before starting the examination. Inside the capsule is a tiny camera that has its own light source; it takes pictures of the patient’s stomach while its movement is controlled by the physician.
ESVIEW ™ SOFTWARE
In a Real-Time View Panel, the software displays the actual anatomical view, a recently captured image(s), and a toolbar for working with the NaviCam® Xpress™. In addition, on this same screen, images and videos taken during the procedure can be studied and exported while viewing the displayed images.
NaviCam® MCCE is a sedation-free alternative for high risk patients and those in which sedation is contraindicated due to co-morbidities or other health risks. Patients can resume normal activities following the procedure.
NaviCam® MCCE is a minimally-invasive alternative where EGD is likely to be of low yield. In the clinical study, there were 110 patients (31.4%) who required biopsy by gastroscopy. Therefore, nearly 70% of patients did not need an invasive gastroscopy after MCCE examination.1
NaviCam® MCCE is an immediate way to address heartburn, stomach pain, etc. for patients on PPI with an instant ruling out of other conditions AND it takes only a little longer than EGD.
NaviCam® MCCE procedures can be scheduled the same day for patients presenting with abdominal pain or heartburn.
In a landmark clinical study, MCCE (the NaviCam® Stomach System) was compared to conventional gastroscopy. The results were published in Clinical Gastroenterology and Hepatology 2016;14:1266-1273. The following are excerpts from that paper: Accuracy of Magnetically Controlled Capsule Endoscopy, Compared With Conventional Gastroscopy, in Detection of Gastric Diseases. Zhuan Liao, *et. al.
Background & Aims: . . . It is impossible to visualize the entire stomach with the passive capsule currently used in practice because of the large size of the gastric cavity. A magnetically controlled capsule endoscopy system (MCCE) has been designed to explore the stomach …
Results: … focal lesions in the whole stomach with 90.4% sensitivity (95% confidence interval [Cl], 84.7%-96.1%) … detected focal lesions in the upper stomach (cardia, fundus, and body) with 90.2% sensitivity (95% Cl, 82.0%-98.4%) and 96.7% specificity (95% Cl, 94.4%-98.9%) … focal lesions in the lower stomach (angulus, antrum, and pylorus) with 90.6% sensitivity (95% Cl, 82.7%-98.4%) and 97.9% specificity (95% Cl, 96.1%-99.7% … (NaviCam®) did not miss any lesions of significance (including tumors or large ulcers).
Discussions: MCCE could be a reliable filter test to stratify patients into those without relevant lesions not requiring further invasive methods, such as gastroscopy.
In this study, there were 110 patients(31.4%) who required biopsy by gastroscopy. Nearly 70% of patients did not need an invasive gastroscopy after MCCE examination. Second, MCCE would be a promising alternative for high-risk patients with peptic ulcers or gastric cancer, ensuring that early lesions would be detected. Conclusions: … NaviCam® detects focal lesions in the upper and lower stomach with comparable accuracy with conventional gastroscopy … is preferred by almost all patients, compared with gastroscopy, and can be used to screen gastric diseases without sedation.